Sponsor

MedImmune LLC

Clinical research sponsor

Published trials101
Recruiting shown0
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell CarcinomaNCT04522323 · lead sponsor · 2020-08-05
ACTIVE_NOT_RECRUITING
A Study Investigating the Pharmacokinetics of a Single Dose Administration of CotadutideNCT04091373 · lead sponsor · 2019-09-27
COMPLETED
A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.NCT04019561 · lead sponsor · 2019-09-23
COMPLETED
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung CancerNCT03794544 · lead sponsor · 2019-03-08
COMPLETED
A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes MellitusNCT03745937 · lead sponsor · 2019-01-07
COMPLETED
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsNCT03811652 · lead sponsor · 2018-12-20
COMPLETED
Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLCNCT03822351 · lead sponsor · 2018-12-19
COMPLETED
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes MellitusNCT03654313 · lead sponsor · 2018-09-28
COMPLETED
A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes MellitusNCT03596177 · lead sponsor · 2018-09-26
COMPLETED
A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese ParticipantsNCT03625778 · lead sponsor · 2018-08-14
COMPLETED
A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well ToleratedNCT03550378 · lead sponsor · 2018-06-29
COMPLETED
A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.NCT03555994 · lead sponsor · 2018-05-31
COMPLETED
Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 DiabetesNCT03444584 · lead sponsor · 2018-05-08
COMPLETED
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination StudyNCT03381274 · lead sponsor · 2018-05-08
ACTIVE_NOT_RECRUITING
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid TumorsNCT03530397 · lead sponsor · 2018-04-24
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese DescentNCT03385369 · lead sponsor · 2018-01-05
COMPLETED
A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382NCT03341013 · lead sponsor · 2017-11-30
COMPLETED
Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382NCT03347968 · lead sponsor · 2017-11-27
COMPLETED
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.NCT03244800 · lead sponsor · 2017-09-04
COMPLETED
Safety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese ParticipantsNCT03096795 · lead sponsor · 2017-05-15
COMPLETED
A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate CancerNCT02991911 · lead sponsor · 2017-01-06
COMPLETED
A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid TumorsNCT02705482 · lead sponsor · 2016-03-30
COMPLETED
A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes MellitusNCT02548585 · lead sponsor · 2015-12-09
COMPLETED
A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 DiabetesNCT02524782 · lead sponsor · 2015-10-07
COMPLETED
A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.NCT02576548 · lead sponsor · 2015-09-23
COMPLETED
A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate AsthmaNCT02512900 · lead sponsor · 2015-09-10
COMPLETED
MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.NCT02503774 · lead sponsor · 2015-07-24
COMPLETED
A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy VolunteersNCT02394314 · lead sponsor · 2015-02-01
COMPLETED
A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese SubjectsNCT02213315 · lead sponsor · 2014-07-01
COMPLETED
Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid ArthritisNCT02277574 · lead sponsor · 2014-06-01
COMPLETED
MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).NCT02088112 · lead sponsor · 2014-03-24
COMPLETED
A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy VolunteersNCT02085473 · lead sponsor · 2014-03-19
COMPLETED
Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib AloneNCT02027961 · lead sponsor · 2013-12-20
COMPLETED
Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe AsthmaNCT02054130 · lead sponsor · 2013-12-13
COMPLETED
A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung CancerNCT02000947 · lead sponsor · 2013-10-25
COMPLETED
Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant MesotheliomaNCT01843374 · lead sponsor · 2013-05-17
ACTIVE_NOT_RECRUITING
Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-110 in Subjects With Rheumatoid ArthritisNCT01878123 · lead sponsor · 2013-04-01
COMPLETED
A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid ArthritisNCT01715896 · lead sponsor · 2013-03-01
COMPLETED
A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid ArthritisNCT01712399 · lead sponsor · 2013-01-28
TERMINATED
A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid ArthritisNCT01706926 · lead sponsor · 2012-08-01
COMPLETED
A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With AsthmaNCT01592396 · lead sponsor · 2012-06-01
COMPLETED
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple SclerosisNCT01585766 · lead sponsor · 2012-04-24
COMPLETED
A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mLNCT01544348 · lead sponsor · 2012-01-01
COMPLETED
A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary DiseaseNCT01448850 · lead sponsor · 2011-11-01
COMPLETED
A Safety and Efficacy Study of Tralokinumab in Adults With AsthmaNCT01402986 · lead sponsor · 2011-08-01
COMPLETED
Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast CancerNCT01446159 · lead sponsor · 2011-06-13
COMPLETED
A Study of the Inflammatory Pathways Associated With Chronic Obstructive Pulmonary Disease ExacerbationsNCT01337661 · lead sponsor · 2011-04-01
COMPLETED
A Study to Evaluate BioMarkers in Blood Samples in Subjects With Rheumatoid ArthritisNCT01209585 · lead sponsor · 2011-03-01
COMPLETED
A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01322594 · lead sponsor · 2011-03-01
COMPLETED
A Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary DiseaseNCT01268072 · lead sponsor · 2011-02-01
TERMINATED
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent AsthmaNCT01334853 · lead sponsor · 2011-01-01
COMPLETED
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung CancerNCT01268059 · lead sponsor · 2010-12-16
TERMINATED
Study to Evaluate the Efficacy and Safety of MEDI-563 in Adults With Uncontrolled AsthmaNCT01238861 · lead sponsor · 2010-12-01
COMPLETED
A Study to Evaluate the Effectiveness of MEDI-563 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01227278 · lead sponsor · 2010-11-01
COMPLETED
An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHFNCT01455402 · lead sponsor · 2010-07-01
COMPLETED
A Study to Evaluate the Efficacy and Safety of CAM-3001 (Drug) in Subjects With Rheumatoid ArthritisNCT01050998 · lead sponsor · 2010-01-05
COMPLETED
A Study to Evaluate the Effectiveness and Safety of MEDI-528 in AdultsNCT00968669 · lead sponsor · 2009-12-01
COMPLETED
Study to Evaluate the Safety and Efficacy of CAT-354NCT00873860 · lead sponsor · 2009-06-01
COMPLETED
A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).NCT00768079 · lead sponsor · 2009-02-02
COMPLETED
A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With AsthmaNCT00783289 · lead sponsor · 2008-11-14
COMPLETED

Sponsor roles

lead sponsor76
collaborator25

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.